GKB Ophthalmics (BOM:533212) Interest Expense: ₹-27 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533212 GKB Ophthalmics Ltd BOM:533212
57 GF Score
Price ₹59.99
GF Value ₹163.94
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GKB Ophthalmics Interest Expense?

GKB Ophthalmics BOM:533212 +0.10% 57 Interest Expense is ₹-27 Mil as of Mar. 2026. GuruFocus rates BOM:533212 with a GF Score™ of 57/100 and a GF Value™ of ₹163.94 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. GKB Ophthalmics's interest expense for the three months ended in Mar. 2026 was ₹ -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-27 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. GKB Ophthalmics's Operating Income for the three months ended in Mar. 2026 was ₹ 23 Mil. GKB Ophthalmics's Interest Expense for the three months ended in Mar. 2026 was ₹ -5 Mil. GKB Ophthalmics's Interest Coverage for the quarter that ended in Mar. 2026 was 4.46. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GKB Ophthalmics  (BOM:533212) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GKB Ophthalmics's Interest Expense for the three months ended in Mar. 2026 was ₹-5 Mil. Its Operating Income for the three months ended in Mar. 2026 was ₹23 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ₹16 Mil.

GKB Ophthalmics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*23.105/-5.177
=4.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

GKB Ophthalmics Interest Expense Historical Data

* Premium members only.

The historical data trend for GKB Ophthalmics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GKB Ophthalmics Interest Expense Chart

GKB Ophthalmics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.14 -12.95 -13.85 -15.73 -18.27

GKB Ophthalmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.30 -7.66 -6.56 -7.35 -5.18
BOM:533212
57GF Score
GKB Ophthalmics Ltd BOM:533212
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GKB Ophthalmics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-27 Mil mean?
GKB Ophthalmics (BOM:533212) has a Interest Expense of ₹-27 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on GKB Ophthalmics and its competitors.
Is GKB Ophthalmics' Interest Expense too high?
GKB Ophthalmics' current Interest Expense is ₹-27 Mil. Overall, GKB Ophthalmics has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Interest Expense compare to ISRG and BDX?
GKB Ophthalmics' Interest Expense of ₹-27 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on GKB Ophthalmics and its competitors. GKB Ophthalmics's current Interest Expense is ₹-27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹163.94, compared to a current price of ₹59.99 — trading 63.4% below its estimated fair value. The current Interest Expense is ₹-27 Mil. GKB Ophthalmics' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Interest Expense is ₹-27 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?

Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued. The current stock price of ₹59.99 is trading 63.4% below its estimated GF Value™ of ₹163.94. GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.

Key valuation signals for BOM:533212:

  • Interest Expense: ₹-27 Mil
  • GF Value™: ₹163.94 vs. price of ₹59.99 (63.4% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GKB Ophthalmics Business Description

Address 16-A, Tivim Industrial Estate, Mapusa, GA, IND, 403 526
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
57GF Score

Get the complete analysis for BOM:533212

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹59.99
Price
₹163.94
GF Value